Vaishali Sanchorawala, MBBS

Professor, Medicine

Vaishali Sanchorawala
732 Harrison Ave


Expertise includes: AL amyloidosis – clinical trials, treatment; Stem cell transplantation; Myeloma.

Other Positions

  • Director, Amyloidosis Center, Boston University School of Medicine
  • Active Staff Hospital Privileges, Medicine, Boston Medical Center


  • Seth G.S. Medical College, MBBS


  • Published on 5/3/2019

    Sanchorawala V, Doros G, Shelton AC. Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis. Am J Hematol. 2019 Jul; 94(7):E194-E196. PMID: 31020691.

    Read at: PubMed
  • Published on 4/6/2019

    Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S. Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body 18F-florbetapir PET/CT. J Nucl Med. 2019 Apr 06. PMID: 30954943.

    Read at: PubMed
  • Published on 1/22/2019

    Sanchorawala V. Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details. Blood Adv. 2019 Jan 22; 3(2):216-218. PMID: 30670538.

    Read at: PubMed
  • Published on 1/21/2019

    Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 Jan 21. PMID: 30664726.

    Read at: PubMed
  • Published on 1/11/2019

    Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 May; 25(5):e169-e173. PMID: 30639823.

    Read at: PubMed
  • Published on 1/3/2019

    Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 Mar; 94(3):E80-E82. PMID: 30575098.

    Read at: PubMed
  • Published on 12/21/2018

    Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019 Feb; 95(2):405-411. PMID: 30580886.

    Read at: PubMed
  • Published on 11/22/2018

    McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V. Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis. Br J Haematol. 2019 Jun; 185(5):998-1001. PMID: 30467849.

    Read at: PubMed
  • Published on 10/25/2018

    Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN, Gertz MA. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018 Oct 25; 4(1):38. PMID: 30361521.

    Read at: PubMed
  • Published on 10/17/2018

    Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood. 2019 Jan 17; 133(3):215-223. PMID: 30333122.

    Read at: PubMed

View 149 more publications: View full profile at BUMC

View all profiles